LOGIN  |  REGISTER
Chimerix

Latest Medical Distribution News

Robert Musslewhite and Sudhakar Ramakrishna to join Cardinal Health Board of Directors

March 10
Last Trade: 125.68 -3.95 -3.05

DUBLIN, Ohio, March 10, 2025 /PRNewswire/ -- Cardinal Health (NYSE:CAH) announced today that its Board of Directors has elected Robert Musslewhite, former Chief Executive Officer of Definitive Healthcare Corp., and Sudhakar Ramakrishna, President and Chief Executive Officer of SolarWinds Corporation, as independent directors, effective March 7, 2025. With more than 20 years of leadership experience, including serving as CEO for two...Read more


Owens & Minor Reports Fourth Quarter & Full Year Financial Results andAnnounces Sale Process Underway for Products & Healthcare Services Segment

February 28
Last Trade: 8.13 -0.03 -0.37

Total Debt Reduction of $244 Million in 2024, Capping a Two-Year Total Debt Reduction of $647 Million 2025 Guidance Midpoint Indicates Double-Digit Adjusted EBITDA & Adjusted EPS Growth, and Improving Cash Flow Active Discussions Well Underway Regarding Potential Sale of Products & Healthcare Services (P&HS) Segment Board of Directors Authorizes Share Repurchase Program of Up to $100 Million RICHMOND, Va. / Feb 28, 2025...Read more


Owens & Minor Launches ByramConnect Digital Health Platform for Diabetes and Other Chronic Health Conditions

February 11
Last Trade: 8.13 -0.03 -0.37

Now available as a free service exclusively to Byram Healthcare customers, ByramConnect powered by the Welldoc App combines digital health coaching, self-tracking, clinically relevant insights and education to support members with diabetes and associated chronic health conditions throughout their health journey. RICHMOND, Va. / Feb 11, 2025 / Business Wire / Byram Healthcare, a leader in home-based care and part of the Owens &...Read more


Prestige Healthcare Reports Record Third Quarter Results and Raises Full-Year Earnings Outlook

February 6
Last Trade: 81.46 -1.39 -1.68

Revenue of $290.3 million in Q3, up 2.7% versus prior year Diluted EPS of $1.22 in Q3 increased approximately 15% versus prior year Reduced leverage to 2.5x in Q3, driven by strong profitability and cash flow Raising full-year fiscal 2025 earnings outlook TARRYTOWN, N.Y., Feb. 06, 2025 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today reported financial results for its third quarter and first nine months ended...Read more


McKesson Reports Fiscal 2025 Third Quarter Results and Raises Full Year Adjusted EPS Guidance

February 5
Last Trade: 661.97 -21.14 -3.09

IRVING, Texas / Feb 05, 2025 / Business Wire / McKesson Corporation (NYSE: MCK) has released its fiscal 2025 third quarter financial results. Results can be accessed on McKesson’s Investor Relations website at investor.mckesson.com/financials/quarterly-results. As previously announced, the company will host a live webcast of the earnings conference call for investors today, Wednesday, February 5th at 4:30 PM ET to review its financial...Read more


Great Elm Reports Fiscal 2025 Second Quarter Financial Results

February 5
Last Trade: 1.87 -0.02 -1.06

PALM BEACH GARDENS, Fla., Feb. 05, 2025 (GLOBE NEWSWIRE) -- Great Elm Group, Inc. (“we,” “our,” “GEG,” “Great Elm,” or “the Company”), (NASDAQ: GEG), an alternative asset manager, today announced financial results for its fiscal second quarter ended December 31, 2024.  Fiscal Second Quarter 2025 and Recent Highlights Great Elm Capital Corp. (NASDAQ: GECC) raised an additional $13.2 million of equity at NAV in December 2024,...Read more


McKesson Advances Specialty Leadership; Signs Agreement to Acquire Controlling Interest in PRISM Vision Holdings

February 4
Last Trade: 661.97 -21.14 -3.09

Acquisition enhances McKesson’s capabilities as a national partner in retina and ophthalmology care IRVING, Texas / Feb 04, 2025 / Business Wire / McKesson Corporation (NYSE: MCK) announced today that it signed a definitive agreement to acquire a controlling interest in PRISM Vision Holdings, LLC (PRISM Vision), a premier provider of general ophthalmology and retina management services, from Quad-C. McKesson will purchase an 80%...Read more


Owens & Minor Launches Financing for Rotech Acquisition and Provides Preliminary Fourth Quarter and Full Year 2024 Financial Results Ahead of Investor Meetings

February 3
Last Trade: 8.13 -0.03 -0.37

Expects to Report Fourth Quarter and Full Year 2024 Financial Results on February 28, 2025 RICHMOND, Va. / Feb 03, 2025 / Business Wire / Owens & Minor, Inc. (NYSE: OMI) (the “Company”) today announced selected preliminary financial results for the fourth quarter and year ended December 31, 2024 in advance of its upcoming earnings announcement and conference call. The release of the preliminary results relates to the Company’s...Read more


Cardinal Health Reports Second Quarter Fiscal Year 2025 Results and Raises Fiscal Year 2025 Outlook

January 30
Last Trade: 125.68 -3.95 -3.05

Revenue decreased 4% to $55.3 billion; revenue increased 16% excluding the impact of the previously communicated large customer contract expiration GAAP1 operating earnings were $549 million; GAAP diluted EPS was $1.65 Non-GAAP operating earnings increased 9% to $635 million, driven by the Pharmaceutical and Specialty Solutions segment; non-GAAP diluted EPS increased 2% to $1.93 Fiscal year 2025 non-GAAP EPS guidance2 raised to $7.85...Read more


Owens & Minor to Present at Upcoming Investor Conferences

December 2
Last Trade: 8.13 -0.03 -0.37

RICHMOND, Va. / Dec 02, 2024 / Business Wire / Owens & Minor, Inc. (NYSE: OMI), announced today that members of its management team are scheduled to participate in two upcoming investor conferences. Citi 2024 Global Healthcare Conference On Wednesday, December 4, 2024, Owens & Minor is scheduled to participate in a fireside chat at 8:45 a.m. ET and host individual investor meetings at the conference in Miami, Florida. Bank of...Read more


Cardinal Health launches Kendall SCD SmartFlow™ Compression System

November 20
Last Trade: 125.68 -3.95 -3.05

Next generation of the Kendall™ SCD Series delivers an all-in-one solution for deep vein thrombosis and pulmonary embolism prevention DUBLIN, Ohio, Nov. 20, 2024 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today the U.S. launch of its Kendall SCD SmartFlow™ Compression System, the next generation of the Kendall™ Compression Series offering an enhanced clinician and patient experience. Featuring clinically proven...Read more


Cardinal Health announces two strategic additions to its portfolio

November 11
Last Trade: 125.68 -3.95 -3.05

Acquisition of a majority stake in GI Alliance, the country's leading gastroenterology management services organization, to accelerate Cardinal Health's multi-specialty growth strategy Acquisition of the Advanced Diabetes Supply Group, a leading national direct-to-patient provider of diabetes medical supplies, to accelerate Cardinal Health's at-Home Solutions growth strategy Company announces plan to hold Investor Day in June...Read more


Great Elm Reports Fiscal 2025 First Quarter Financial Results

November 11
Last Trade: 1.87 -0.02 -1.06

PALM BEACH GARDENS, Fla., Nov. 11, 2024 (GLOBE NEWSWIRE) -- Great Elm Group, Inc. (“we,” “our,” “GEG,” “Great Elm,” or “the Company”), (NASDAQ: GEG), an alternative asset manager, today announced financial results for its fiscal first quarter ended September 30, 2024. Fiscal First Quarter 2025 and Recent Highlights GEG’s fee-paying assets under management (“FPAUM”) and assets under management (“AUM”) totaled approximately $559 million...Read more


Prestige Consumer Healthcare Reports Second Quarter and First Half Fiscal 2025 Results

November 7
Last Trade: 81.46 -1.39 -1.68

Revenue of $283.8 Million in Q2, Ahead of Outlook Diluted EPS of $1.09 in Q2, Up 2% Versus Prior Year Net Cash Provided by Operating Activities of Approximately $125 Million in First Six Months, Up Approximately 13%; Reduced Debt by $75 Million and Repurchased $38 Million Shares Year-to-Date Reaffirming Full-Year Fiscal 2025 Revenue, Earnings, and Cash Flow Outlook TARRYTOWN, N.Y., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Prestige...Read more


McKesson Reports Fiscal 2025 Second Quarter Results and Raises Full Year Adjusted EPS Guidance

November 6
Last Trade: 661.97 -21.14 -3.09

IRVING, Texas / Nov 06, 2024 / Business Wire / McKesson Corporation (NYSE: MCK) has released its fiscal 2025 second quarter financial results. Results can be accessed on McKesson’s Investor Relations website at investor.mckesson.com/financials/quarterly-results. As previously announced, the company will host a live webcast of the earnings conference call for investors today, Wednesday, November 6th at 4:30 PM ET to review its financial...Read more


Owens & Minor Reports Third Quarter 2024 Financial Results

November 4
Last Trade: 8.13 -0.03 -0.37

Top-Line Growth Driven by Continued Solid Demand in Patient Direct and Medical Distribution Total Debt Reduction of Nearly $200 Million in the Third Quarter RICHMOND, Va. / Nov 04, 2024 / Business Wire / Owens & Minor, Inc. (NYSE: OMI) today reported financial results for the third quarter ended September 30, 2024. Key Highlights: Consolidated revenue of $2.7 billion in the third quarter, representing year-over-year growth of...Read more


Cardinal Health Reports First Quarter Fiscal Year 2025 Results and Raises Fiscal Year 2025 Outlook

November 1
Last Trade: 125.68 -3.95 -3.05

Revenue decreased 4% to $52.3 billion; revenue increased 15% excluding the impact of the previously communicated large customer contract expiration GAAP1 operating earnings were $568 million; GAAP diluted EPS was $1.70 Non-GAAP operating earnings increased 12% to $625 million, driven by significant growth in Pharmaceutical and Specialty Solutions segment profit Non-GAAP diluted EPS increased 9% to $1.88 Fiscal year 2025 non-GAAP EPS...Read more


Cardinal Health celebrates medical product distribution center grand opening in Massachusetts

October 29
Last Trade: 125.68 -3.95 -3.05

New facility in Boylston increases U.S. warehouse capacity and expands specialized handling capabilities DUBLIN, Ohio, Oct. 29, 2024 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today the grand opening of its new distribution center in Boylston, Massachusetts, supporting its U.S. Medical Products and Distribution business. The facility provides healthcare customers in Massachusetts, New Hampshire, Rhode Island, Maine,...Read more


Cardinal Health to acquire Integrated Oncology Network, a physician-led independent community oncology network

September 20
Last Trade: 125.68 -3.95 -3.05

Transaction demonstrates Cardinal Health's continued strategic investment in specialty and oncology, underscores commitment to independent community healthcare providers  Accelerates the development of Navista oncology practice alliance, adding more than 100 providers at more than 50 community-based sites delivering broad-reaching oncology and urology care across 10 states DUBLIN, Ohio, Sept. 20, 2024 /PRNewswire/ --...Read more


Telix Pharmaceuticals Announces Cardinal Health as U.S. Commercial Distributor for Zircaix®

September 17
Last Trade: 125.68 -3.95 -3.05

MELBOURNE, Australia, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that it has selected Cardinal Health, Inc. (NYSE: CAH, Cardinal Health) as a commercial radiopharmaceutical distributor to supply finished unit doses of its PET1 agent, Zircaix®2 (TLX250-CDx) for the imaging of kidney cancer in the United States (U.S.), subject to regulatory approval. In preparation for a...Read more


Owens & Minor Announces New Partnership with Google Cloud

September 10
Last Trade: 8.13 -0.03 -0.37

Collaboration will enhance existing QSight capabilities and enable future platform and service innovations to help optimize complex inventory management for hospitals and health systems RICHMOND, Va. / Sep 10, 2024 / Business Wire / Owens & Minor, Inc. today announced a new partnership with Google Cloud that combines Owens & Minor’s deep expertise in optimizing the healthcare supply chain with Google Cloud’s Vertex AI platform...Read more


Owens & Minor to Present at the 2024 Baird Global Healthcare Conference

September 9
Last Trade: 8.13 -0.03 -0.37

RICHMOND, Va. / Sep 09, 2024 / Business Wire / Owens & Minor, Inc. (NYSE: OMI), announced today that Ed Pesicka, the Company’s President and Chief Executive Officer and Jon Leon, Corporate Treasurer and interim Chief Financial Officer, will participate in a fireside chat at 1:25 p.m. Eastern Daylight Time on Tuesday, September 10, 2024 at Baird’s Global Healthcare Conference in New York City. Owens & Minor is also hosting one-on-one...Read more


Prestige Consumer Healthcare to Present at the Barclays Global Consumer Staples Conference

September 3
Last Trade: 81.46 -1.39 -1.68

TARRYTOWN, N.Y., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced it will present at the Barclays Global Consumer Staples Conference on Thursday, September 5, 2024 at 2:15 p.m. ET.  All interested parties may access a live webcast of this event at www.prestigeconsumerhealthcare.com under the "Investors” section and the "Events and Presentations"...Read more


Great Elm Reports Fiscal 2024 Fourth Quarter and Full Year Financial Results

August 29
Last Trade: 1.87 -0.02 -1.06

PALM BEACH GARDENS, Fla., Aug. 29, 2024 (GLOBE NEWSWIRE) -- Great Elm Group, Inc. (“we,” “our,” “GEG,” “Great Elm,” or “the Company”), (NASDAQ: GEG), an alternative asset manager, today announced financial results for its fiscal fourth quarter and year ended June 30, 2024.  Fiscal Fourth Quarter 2024 and Recent Highlights Great Elm Capital Corp. (“GECC”) raised $34 million of additional debt and equity capital since April...Read more


McKesson Signs Agreement to Acquire Controlling Interest in Florida Cancer Specialists & Research Institute’s Core Ventures

August 26
Last Trade: 661.97 -21.14 -3.09

Acquisition enhances McKesson’s integrated oncology platform; Florida Cancer Specialists & Research Institute to join The US Oncology Network IRVING, Texas / Aug 26, 2024 / Business Wire / McKesson Corporation (NYSE: MCK) announced today that it signed a definitive agreement to acquire a controlling interest in Community Oncology Revitalization Enterprise Ventures, LLC (Core Ventures). Core Ventures, a business and administrative...Read more


Cardinal Health expands medical product distribution footprint in Northeast Ohio

August 21
Last Trade: 125.68 -3.95 -3.05

New facility opening in Walton Hills demonstrates ongoing commitment to increase U.S. warehouse capacity and modernize operations   DUBLIN, Ohio, Aug. 21, 2024 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today its plans to open a new distribution center in Walton Hills, Ohio, supporting its U.S. Medical Products and Distribution business. The facility will integrate new technology solutions, deliver operational...Read more


Cardinal Health Reports Fourth Quarter and Fiscal Year 2024 Results and Raises Fiscal Year 2025 Guidance

August 14
Last Trade: 125.68 -3.95 -3.05

Fourth quarter revenue increased 12% to $59.9 billion Fourth quarter GAAP1 operating earnings were $401 million and GAAP diluted EPS was $0.96 Fourth quarter non-GAAP operating earnings increased 14% to $605 million and non-GAAP diluted EPS increased 29% to $1.84 Fiscal Year 2024 operating cash flow and adjusted free cash flow reached all-time highs of $3.8 billion and $3.9 billion, respectively Fiscal year 2025 non-GAAP EPS...Read more


Prestige Consumer Healthcare Reports First Quarter Fiscal 2025 Results

August 8
Last Trade: 81.46 -1.39 -1.68

Revenue of $267.1 Million in Q1, Ahead of Expectations, down 4.4% versus Prior Year EPS of $0.98 and Adjusted EPS of $0.90 in Q1 Compared to $1.06 in the Prior Year Cash from Operations of $54.8 Million up 13.9% versus Prior Year; Reduced Debt by $35 Million and Repurchased $26 Million Shares Reaffirming Full-Year Fiscal 2025 Revenue, Earnings, and Cash Flow Outlook TARRYTOWN, N.Y., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Prestige...Read more


McKesson Reports Fiscal 2025 First Quarter Results

August 7
Last Trade: 661.97 -21.14 -3.09

IRVING, Texas / Aug 07, 2024 / Business Wire / McKesson Corporation (NYSE: MCK) has released its fiscal 2025 first quarter financial results. Results can be accessed on McKesson’s Investor Relations website at investor.mckesson.com/financials/quarterly-results. As previously announced, the company will host a live webcast of the earnings conference call for investors today, Wednesday, August 7th at 4:30 PM ET to review its financial...Read more


Owens & Minor Reports Second Quarter 2024 Financial Results

August 2
Last Trade: 8.13 -0.03 -0.37

Top Line Expansion Driven by Solid Growth in Both Segments Second Quarter Operating Cash Flow of $116 Million Drove $71 million in Debt Reduction Expanding Patient Direct Segment with Agreement to Acquire Rotech Healthcare Holdings RICHMOND, Va. / Aug 02, 2024 / Business Wire / Owens & Minor, Inc. (NYSE: OMI) today reported financial results for the second quarter ended June 30, 2024. Key Highlights: Consolidated revenue of...Read more


Owens & Minor Releases Preliminary Second Quarter 2024 Financial Results & Reaffirms 2024 Annual Guidance

July 23
Last Trade: 8.13 -0.03 -0.37

Plans to Release Full Results on Friday, August 2 Before the NYSE Open RICHMOND, Va. / Jul 23, 2024 / Business Wire / Owens & Minor, Inc. (NYSE: OMI) today announced selected preliminary financial results for the quarter ended June 30, 2024 as noted in the table below. The Company also reaffirmed its outlook for the full year 2024 as noted below in advance of its second quarter 2024 earnings announcement and conference...Read more


Owens & Minor Signs Definitive Agreement to Acquire Rotech Healthcare for $1.36 Billion in Cash

July 23
Last Trade: 8.13 -0.03 -0.37

Strategy Articulated at Investor Day is Advanced by Strengthening Our Patient Direct Segment’s Position as a Premier Growth Platform in Home-Based Care Combined Capabilities Support Improved Service to Patients, Providers, and Payors Adjusted EPS Neutral in First Full Year and Approximately $0.15 Accretion in Second Year Company Reports Preliminary Second Quarter Results and Reaffirms 2024 Full Year Guidance in Separate Press...Read more


Prestige Consumer Healthcare to Present at the Oppenheimer Annual Consumer Growth and E-Commerce Conference

June 6
Last Trade: 81.46 -1.39 -1.68

TARRYTOWN, N.Y., June 06, 2024 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced it will present at the Oppenheimer Annual Consumer Growth and E-Commerce Conference on Monday, June 10, 2024 at 1:30 p.m. ET. All interested parties may access a live webcast of this event at www.prestigeconsumerhealthcare.com under the "Investors” section and the "Events and Presentations" tab, or by using the following...Read more


Owens & Minor to Present at the Leerink Partners’ Healthcare Crossroads Conference on May 29, 2024

May 28
Last Trade: 8.13 -0.03 -0.37

RICHMOND, Va. / May 28, 2024 / Business Wire / Owens & Minor, Inc. (NYSE: OMI), a global healthcare solutions company that provides healthcare products for home-based care, self-manufactured products, proprietary product portfolio, distribution services and innovative technology, announced today that Ed Pesicka, the Company’s President and Chief Executive Officer and Alex Bruni, the Company’s Executive Vice President and Chief Financial...Read more


Prestige Consumer Healthcare Reports Fiscal Year 2024 Results

May 14
Last Trade: 81.46 -1.39 -1.68

Revenue of $277.0 Million in Q4 and $1,125.4 Million in Fiscal 2024 Solid Consumption Trends in Q4 Offset by Near-Term Supply Chain Constraints Achieved Leverage Ratio of 2.8x at Year-End, Below Long-Term Target Board of Directors Authorize New $300 Million Share Repurchase Program Initial Full-Year Fiscal 2025 Organic Revenue Growth and EPS Outlook of Approximately 1% and $4.40 to $4.46, respectively TARRYTOWN, N.Y., May 14,...Read more


Owens & Minor to Present at the BofA Securities 2024 Health Care Conference on May 15, 2024

May 13
Last Trade: 8.13 -0.03 -0.37

RICHMOND, Va. / May 13, 2024 / Business Wire / Owens & Minor, Inc. (NYSE: OMI), a global healthcare solutions company that provides healthcare products for home-based care, self-manufactured products, proprietary product portfolio, distribution services and innovative technology, announced today that Alex Bruni, the Company’s Executive Vice President and Chief Financial Officer and Jonathan Leon, the Company’s Senior Vice...Read more


Great Elm Group Reports Fiscal 2024 Third Quarter Financial Results

May 8
Last Trade: 1.87 -0.02 -1.06

PALM BEACH GARDENS, Fla., May 08, 2024 (GLOBE NEWSWIRE) -- Great Elm Group, Inc. (“we,” “our,” “GEG,” “Great Elm,” or “the Company”), (NASDAQ: GEG), an alternative asset manager, today announced financial results for its fiscal third quarter ended March 31, 2024. Fiscal Third Quarter 2024 and Other Recent Highlights Great Elm Capital Corp. (“GECC”), raised approximately $58.5 million new capital since December 31, 2023, positioning...Read more


McKesson Reports Fiscal 2024 Fourth Quarter and Full Year Results

May 7
Last Trade: 661.97 -21.14 -3.09

IRVING, Texas / May 07, 2024 / Business Wire / McKesson Corporation (NYSE: MCK) has released its fiscal 2024 fourth quarter financial results. Results can be accessed on McKesson’s Investor Relations website at investor.mckesson.com/financials/quarterly-results. As previously announced, the company will host a live webcast of the earnings conference call for investors today, Tuesday, May 7th at 4:30 PM ET to review its financial results....Read more


Owens & Minor Reports First Quarter 2024 Financial Results

May 3
Last Trade: 8.13 -0.03 -0.37

Gross Margin Expansion of 79 Basis Points Adjusted EPS Growth of Nearly Four Times with GAAP EPS Loss of $(0.29) and Adjusted EPS of $0.19 Investments Outlined at 2023 Investor Day for Long-Term Growth are Ahead of Plan RICHMOND, Va. / May 03, 2024 / Business Wire / Owens & Minor, Inc. (NYSE: OMI) today reported financial results for the first quarter ended March 31, 2024. Key Highlights: Consolidated revenue of $2.6 billion...Read more


Cardinal Health Reports Third Quarter Fiscal Year 2024 Results and Raises Fiscal Year 2024 Non-GAAP EPS Guidance

May 2
Last Trade: 125.68 -3.95 -3.05

Revenue increased 9% to $54.9 billion GAAP1 operating earnings were $367 million; GAAP diluted EPS was $1.05 Non-GAAP operating earnings increased 10% to $666 million; non-GAAP diluted EPS increased 20% to $2.08 Fiscal year 2024 non-GAAP EPS guidance2 raised and narrowed to $7.30 to $7.40, from $7.20 to $7.35 Company provides preliminary fiscal year 2025 non-GAAP EPS guidance of at least $7.50 DUBLIN, Ohio, May 2, 2024 ...Read more


Sign Up To Get Daily
Life Science News

Please review our Disclaimer and Privacy Policy before subscribing.

Featured Stock

Chimerix

Chimerix is on a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The company is devoted to filling gaps in the treatment paradigm. Chimerix’s most advanced clinical-stage program is in development for H3 K27M-mutant glioma....

CLICK TO LEARN MORE